Hello everyone. I recently started on X; I'm Yuki-kun, an amateur investor and certification collector. My daily routine consists of looking at investment chart analysis and certification textbooks, ...
Trump said generic drugs imported into the U.S. will face zero tariffs for two years from August 1. The rate will rise to 100% in 2028, before doubling a year later. The latest tariff salvo ...
President Donald Trump on Tuesday announced a plan to impose a 100 percent tariff on generic drugs starting in August 2028 as part of a bid to push pharmaceutical production back to the United States.
A multiyear “tariff cliff” sets 0% through July 2028, then 100% for one year and 200% thereafter, explicitly tying penalties to failure to establish US manufacturing capacity. Sparse implementation ...
Anthropic is changing its data retention policies for its new Mythos-class models. Credit: Nicolas TUCAT / AFP via Getty Images Anthropic just released its most powerful public model yet — Claude ...
The regulators of Colorado’s first-in-the-nation recreational marijuana market have allowed so many sham transactions in the industry to proliferate that honest cultivators and manufacturers shoulder ...
President Trump announced the addition of 600 medicines to his online drugstore as he appeals to Americans concerned about high drug prices and affordability. By Rebecca Robbins President Trump said ...
Nahda Nabiilah is a Staff Writer from Indonesia. She has always loved writing and playing games, so one day she decided to combine the two. She couldn't believe that she could make a career out of two ...
Pfizer inking the last of three settlements to postpone copycats to its transthyretin amyloid cardiomyopathy (ATTR-CM) med Vyndamax was expected to signal good news for BridgeBio and its rival therapy ...
In the late 1990s, Jay-Z was ushered into a vault room at an unspecified location—“one of these buildings I didn’t know existed,” as he mysteriously describes it—and reemerged with an exceedingly rare ...
Over the last year, Sanofi has been busy reshaping itself to focus more on innovative drugs, including selling a controlling stake in its former consumer business and using those proceeds to strike a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results